Global Bioprocessing Automation Market, 2022-2030

The biopharmaceutical industry has lagged behind other industries, such as oil and gas, as well as the semi-conductor sectors, which have been using automation since 2000. One reason for the biopharmaceutical industry being behind is that unlike many other industrial processes, bioprocessing is not binary and generally involves complex living cells where variability is high making measurement and predictions of bioprocess performance challenging.

Single User	Enterprise License, Single User License, Team License

Report Summary

Revolutionize the way you engage with data through our cutting-edge interactive dashboard(Click to enlarge)

• The biopharmaceutical industry has lagged behind other industries, such as oil and gas, as well as the semi-conductor sectors, which have been using automation since 2000. One reason for the biopharmaceutical industry being behind is that unlike many other industrial processes, bioprocessing is not binary and generally involves complex living cells where variability is high making measurement and predictions of bioprocess performance challenging.
• The industry is also heavily regulated, with special constraints around contamination and safety, where changes to a Good Manufacturing Process Compliant (cGMP) locked down process are viewed by bioprocess scientists as tricky to implement. Another reason is that process automation capable of culturing cells and purifying biologics in bioprocessing was in its infancy in 2000, as were scale-down models for predicting process performance and Process Analytical Technology (PAT) tools for real-time bioprocess monitoring.
• In general, upstream is further down the bioprocessing automation road in terms of connectedness and digitization than downstream. This is because downstream processing relies on more traditional, less automated equipment and techniques; which means there is less opportunity to collect meaningful data and control processes, leading to high variability in downstream bioprocessing.
• Biopharmaceutical manufacturers are being driven to adopt bioprocessing automation by market pressures to produce biologics in a shorter timeframe without compromising product quality and safety. Integration of statistical modeling with standard bioprocess automation methods has also been a positive strategy in achieving the goals of faster production time and better process design.

• North America dominated the single-use bioprocessing market with a revenue share of 38.2% in 2021. The expanding biopharmaceutical R&D coupled with the presence of large-scale biopharmaceutical manufacturing facilities in the U.S. has majorly contributed to the dominance of the region. Furthermore, the North America region is home to many contract manufacturing organizations that are engaged in automating their workflows.

Table of Content

1.    Report Scope

1.1. Market Segmentation and scope

1.2. Regional Scope

1.3. Estimates and forecast timeline

2.     Market Research Methodology

2.1. Research methodology and design

2.2. Sample selection

2.3. Reliability and validity

3.    Executive Summary

4.    Market Analysis

4.1. Market size and growth rates

4.2. Market growth drivers, market dynamics and trends

4.3. Market scenarios and opportunity forecasts

4.4. Market constraints and challenges

4.5. Industry value chain analysis

4.6. Industry analysis – Porter’s

4.6.1.  Threat of new entrants

4.6.2.  Bargaining power of suppliers

4.6.3.  Bargaining power of buyers

4.6.4.  Threat of substitutes

4.6.5.  Competitive rivalry

4.7. PEST analysis

4.7.1.  Political/legal landscape

4.7.2.  Economic landscape

4.7.3.  Social landscape

4.7.4.  Technological landscape

5.     Market Breakdown – by Product Type

5.1. Introduction

5.2. Software

5.2.1.  Automation software

5.2.2.  Additional software

5.3. Hardware

5.3.1.  Server infrastructure

5.3.2.  Network infrastructure

5.3.3.  Others

5.4. Maintenance and Support Services

6.     Market Breakdown – by Application

6.1. Introduction

6.2. Chromatography

6.3. Cell Culture

6.4. Cell Therapy

6.5. Mixing, Harvest

6.6. Filtration

6.7. Others

7.     Market Breakdown – by End-User

7.1. Introduction

7.2. Biotech / Biopharmaceutical Companies

7.3. CDMO / Contract Research Organization

7.4. Research / Academic Institutes

8.      Market Breakdown – by Geography

8.1. North America

8.1.1.  North America Bioprocessing Automation Market, 2022-2030

8.1.2.  North America Bioprocessing Automation Market, by Product Type

8.1.3.  North America Bioprocessing Automation Market, by Application

8.1.4.  North America Bioprocessing Automation Market, by End-User

8.1.5.  North America Bioprocessing Automation Market, by Country

8.1.5.1.      U.S.

8.1.5.2.      Canada

8.1.5.3.      Mexico

8.2. South America

8.2.1.  South America Bioprocessing Automation Market, 2022-2030

8.2.2.  South America Bioprocessing Automation Market, by Product Type

8.2.3.  South America Bioprocessing Automation Market, by Application

8.2.4.  South America Bioprocessing Automation Market, by End-User

8.2.5.  South America Bioprocessing Automation Market, by Country

8.2.5.1.      Brazil

8.2.5.2.      Argentina

8.2.5.3.      Others

8.3. Europe

8.3.1.  Europe Bioprocessing Automation Market, 2022-2030

8.3.2.  Europe Bioprocessing Automation Market, by Product Type

8.3.3.  Europe Bioprocessing Automation Market, by Application

8.3.4.  Europe Bioprocessing Automation Market, by End-User

8.3.5.  Europe Bioprocessing Automation Market, by Country

8.3.5.1.      UK

8.3.5.2.      Germany

8.3.5.3.      France

8.3.5.4.      Russia

8.3.5.5.      Italy

8.3.5.6.      Spain

8.3.5.7.      Sweden

8.3.5.8.      Switzerland

8.3.5.9.      Others  

8.4. Asia-Pacific

8.4.1.  APAC Bioprocessing Automation Market, 2022-2030

8.4.2.  APAC Bioprocessing Automation Market, by Product Type

8.4.3.  APAC Bioprocessing Automation Market, by Application

8.4.4.  APAC Bioprocessing Automation Market, by End-User

8.4.5.  APAC Bioprocessing Automation Market, by Country

8.4.5.1.      China

8.4.5.2.      India

8.4.5.3.      Japan

8.4.5.4.      South Korea

8.4.5.5.      Australia

8.4.5.6.      Others   

8.5.Middle East & Africa

8.5.1.  MEA Bioprocessing Automation Market, 2022-2030

8.5.2.  MEA Bioprocessing Automation Market, by Product Type

8.5.3.  MEA Bioprocessing Automation Market, by Application

8.5.4.  MEA Bioprocessing Automation Market, by End-User

8.5.5.  MEA Bioprocessing Automation Market, by Country

8.5.5.1.      South Africa

8.5.5.2.      UAE

8.5.5.3.      Saudi Arabia

8.5.5.4.      Israel  

8.5.5.5.      Others

9.      Competitive Landscape

9.1. Company Market Positioning

9.2. Company Geographical Presence Analysis

9.3. Market Revenue Share Analysis (%), by Leading Players

10.  Company Profiles

·          Company Overview

·          Financial Performance

·          Product Benchmarking

·          Recent Developments

10.1.              Applikon Biotechnology (Getinge)

10.2.              BIONET

10.3.              Cytiva (Danaher)

10.4.              Eppendorf

10.5.              Genedata

10.6.              INFORS HT

10.7.              Körber Pharma

10.8.              Merck Millipore

10.9.              Pierre Guérin SAS

10.10.          Rockwell Automation

10.11.          Sartorius AG

10.12.          Securecell

10.13.          Solaris Biotech

10.14.          Synthace

10.15.          Thermo Fisher Scientific

 

Request Sample

Buy Now